Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma

SNA001 is a novel recombinant human thyroid stimulating hormone (rhTSH). rhTSH has long been approved in several countries to facilitate monitoring and ablation of thyroid carcinoma without hypothyroidism caused by thyroid hormone withdrawal (THW). To assess the safety, tolerance, pharmacokinetic an...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yushen Gu, Hongrong Xu, Yanling Yang, Yan Xiu, Pengcheng Hu, Min Liu, Xiangqing Wang, Jun Song, Yan Di, Jian Wang, Xiaoxia Zhang, Tao Xu, Xuening Li, Hongcheng Shi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-02-01
Edice:	Frontiers in Endocrinology
Témata:	rhTSH differentiated thyroid carcinoma whole body scan thyroglobulin iodine-131
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fendo.2020.615883/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!